Don't Mess with the Machine - Evaluation of Fluconazole Susceptibility Testing for Candida Glabrata Using the New VITEK2 AST-YS08 Card Following Species Modification
Overview
Microbiology
Pathology
Authors
Affiliations
A modification of fluconazole formulation in the VITEK2 AST-YS08 card revoked the fluconazole-Candida glabrata combination. An evaluation of AST-YS08 following C. glabrata to C. albicans adjustment within VITEK2 software revealed higher fluconazole MICs compared to AST-YS07 and E-test, with major discrepancies. This mandates an alternative approach to fluconazole-C. glabrata susceptibility testing.
ElFeky D, El-Wakil D, Mwafy M, Atia M, Gohar N BMC Infect Dis. 2025; 25(1):114.
PMID: 39856577 PMC: 11760087. DOI: 10.1186/s12879-024-10435-8.
Siopi M, Pachoulis I, Leventaki S, Spruijtenburg B, Meis J, Pournaras S J Clin Microbiol. 2024; 62(4):e0152823.
PMID: 38501836 PMC: 11005389. DOI: 10.1128/jcm.01528-23.
Lee H, Choi S, Oh J, Koo J, Lee H, Cho S Microbiol Spectr. 2022; 10(2):e0125321.
PMID: 35384691 PMC: 9045382. DOI: 10.1128/spectrum.01253-21.
Lim H, Shin J, Kim M, Yong D, Byun S, Choi M Antimicrob Agents Chemother. 2020; 64(11).
PMID: 32900684 PMC: 7577149. DOI: 10.1128/AAC.00740-20.